At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
Receiver-in-canal hearing instrumentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Examine the Performance of a Hearing Aid Transducer During Typical, In-field Use
In Brief
A clinical study evaluating Receiver-in-canal hearing instrument for Hearing Loss. Completed, enrolled 35 participants across 1 site.
Detailed Summary
Study participants will be fit with previously released receiver-in-canal (RIC) hearing instruments. Participants will be asked to wear the instruments in their daily life for a minimum of 3 months, but have the option to continue to wear devices for six months.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartAug 2020
First PostedMar 2021
Primary CompletionSep 2021
Study CompletionDec 2021
TodayJul 2026
First PostedMar 8, 2021
Enrollment StartAug 1, 2020
Primary CompletionSep 30, 2021
Study CompletionDec 31, 2021
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.3 years ago
Interventions
Receiver-in-canal hearing instrumentdevice
Receiver-in-canal hearing instrument